Apatinib for heavily treated patients with non-small cell lung cancer: Report of a case series and literature review
In conclusion, apatinib shows some efficacy in heavily treated NSCLC and generally tolerable toxicity in non-squamous NSCLC. More solid evidence will be accessible in near future.
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Clinical Trials | Lung Cancer | Middle East Health | Non-Small Cell Lung Cancer | Oral Cancer | Saudi Arabia Health | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology